Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suravi Raychaudhuri

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Dermatology|June 26, 2014
The blue nails of argyriaSiba P Raychaudhuri, Suravi Raychaudhuri
Plos One|May 24, 2016
Imposed Optical Defocus Induces Isoform-Specific Up-Regulation of TGFβ Gene Expression in Chick Retinal Pigment Epithelium and Choroid but Not Neural RetinaYan Zhang, Suravi Raychaudhuri, Christine F Wildsoet
Indian Journal of Dermatology|April 5, 2014
Immunomodulatory mechanisms of action of calcitriol in psoriasisSuravi Raychaudhuri, Anupam Mitra, Ananya Datta-Mitra
Case Reports in Hematology|September 18, 2024
EBV-Positive Classic Hodgkin Lymphoma and Primary Nodal T-Cell/NK-Cell Lymphoma Arising in the Background of Follicular LymphomaSuravi Raychaudhuri, Zhao Ming Dong, Scott Knowles, et al.
Hematology. American Society of Hematology. Education Program|December 5, 2025
Peri-transplant conundrums: optimizing maintenance therapy using MRD-directed approachesSuravi Raychaudhuri, Ryan D Cassaday, Mary-Elizabeth M Percival
Current Opinion in Rheumatology|May 20, 2021
Janus kinase-signal transducers and activators of transcription cell signaling in Spondyloarthritis: rationale and evidence for JAK inhibitionSuravi Raychaudhuri, Karmtej Singh Cheema, Smriti K Raychaudhuri, et al.
JAMA Dermatology|June 22, 2022
Association of a Dominant T-Cell Clone in Peripheral Blood With Time to Systemic Treatment in Patients With Stage IB Mycosis FungoidesSuravi Raychaudhuri, Yann Charli-Joseph, Chiung-Yu Huang, et al.
Blood Neoplasia|August 12, 2025
Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapySuravi Raychaudhuri, Megan Othus, Mary-Elizabeth M Percival, et al.
Leukemia|January 27, 2025
Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203Megan Othus, Guillermo Garcia-Manero, Frederick R Appelbaum, et al.
Blood Neoplasia|June 19, 2025
Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasmSuravi Raychaudhuri, Ted A Gooley, Allegra Rasmussen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Dermatology|June 26, 2014
The blue nails of argyriaSiba P Raychaudhuri, Suravi Raychaudhuri
Plos One|May 24, 2016
Imposed Optical Defocus Induces Isoform-Specific Up-Regulation of TGFβ Gene Expression in Chick Retinal Pigment Epithelium and Choroid but Not Neural RetinaYan Zhang, Suravi Raychaudhuri, Christine F Wildsoet
Indian Journal of Dermatology|April 5, 2014
Immunomodulatory mechanisms of action of calcitriol in psoriasisSuravi Raychaudhuri, Anupam Mitra, Ananya Datta-Mitra
Case Reports in Hematology|September 18, 2024
EBV-Positive Classic Hodgkin Lymphoma and Primary Nodal T-Cell/NK-Cell Lymphoma Arising in the Background of Follicular LymphomaSuravi Raychaudhuri, Zhao Ming Dong, Scott Knowles, et al.
Hematology. American Society of Hematology. Education Program|December 5, 2025
Peri-transplant conundrums: optimizing maintenance therapy using MRD-directed approachesSuravi Raychaudhuri, Ryan D Cassaday, Mary-Elizabeth M Percival
Current Opinion in Rheumatology|May 20, 2021
Janus kinase-signal transducers and activators of transcription cell signaling in Spondyloarthritis: rationale and evidence for JAK inhibitionSuravi Raychaudhuri, Karmtej Singh Cheema, Smriti K Raychaudhuri, et al.
JAMA Dermatology|June 22, 2022
Association of a Dominant T-Cell Clone in Peripheral Blood With Time to Systemic Treatment in Patients With Stage IB Mycosis FungoidesSuravi Raychaudhuri, Yann Charli-Joseph, Chiung-Yu Huang, et al.
Blood Neoplasia|August 12, 2025
Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapySuravi Raychaudhuri, Megan Othus, Mary-Elizabeth M Percival, et al.
Leukemia|January 27, 2025
Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203Megan Othus, Guillermo Garcia-Manero, Frederick R Appelbaum, et al.
Blood Neoplasia|June 19, 2025
Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasmSuravi Raychaudhuri, Ted A Gooley, Allegra Rasmussen, et al.
Pageof 2